1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
July 24, 2006
Date of Report
(Date of Earliest Event Reported)
NATIONAL HEALTHCARE TECHNOLOGY, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Colorado 0-28911 91-1869677
---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
1660 Union Street, Suite 200
San Diego, California 92101
----------------------------------------
(Address of principal executive offices)
(619) 398-8470
-----------------------------
Registrant's telephone number
21800 Oxnard Street, Suite 440
Woodland Hills, CA 91367
-------------------------------
Former name and former address
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 4.01 Changes in Registrant's Certifying Accountant
---------------------------------------------
Effective July 25, 2006, National Healthcare Technology, Inc. (the "Company")
dismissed its prior independent public accountant, Lopez, Blevins, Bork &
Associates, LLP and retained as its new independent public accountant Kabani &
Company, Inc. Lopez, Blevins, Bork & Associates, LLP's report on the Company's
financial statements during the most recent fiscal year contained no adverse
opinion or disclaimer of opinion, nor was it qualified or modified as to
uncertainty, audit scope or accounting principles, except that the report was
qualified as to the Company's ability to continue as a going concern.
The decision to change accountants was approved by the Company's Board of
Directors.
During the last two fiscal years and the subsequent interim period through July
25, 2006, there were no disagreements between the Company and Lopez, Blevins,
Bork & Associates, LLP on any matters of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of Lopez, Blevins, Bork &
Associates, LLP, would have caused it to make a reference to the subject matter
of disagreements in connection with its report. There were no "reportable
events" as that term is described in Item 304(a)(1)(v) of Regulation S-B within
the last fiscal year and through July 25, 2006.
The Company has made the contents of this Form 8-K available to Lopez, Blevins,
Bork & Associates, LLP and has requested Lopez, Blevins, Bork & Associates, LLP
to furnish it with a letter addressed to the Securities and Exchange Commission
stating whether Lopez, Blevins, Bork & Associates, LLP agrees or disagrees with,
or wishes to clarify the Company's expression of their views within 10 business
days.
Effective July 25, 2006, the Company engaged Lopez, Blevins, Bork & Associates,
LLP as its new independent registered public accountants to audit the Company's
financial statements. The appointment of Lopez, Blevins, Bork & Associates, LLP
was recommended and approved by the Company's board of directors. During the
Company's last two most recent fiscal years and the subsequent interim period to
date hereof, the Company has not consulted Kabani & Company, Inc. regarding
either: (1) the application of accounting principles to a specified transaction,
-2-
either complete or proposed, or the type of audit opinion that might be rendered
on the Company's financial statements, or (2) any matter that was either the
subject matter of a disagreement as defined in Item 304(a)(1)(iv) of Regulation
S-B or a reportable event as described in Item 304(a)(1)(v) of Regulation S-B.
Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
5.02(b)
The Company's Chief Executive Officer and director, Ross Lyndon-James, resigned
from the Company effective July 24, 2006 and the Company's Chief Financial
Officer and director, Brian Harcourt, resigned from the Company effective July
24, 2006.
5.02(c)&(d)
The Company appointment of Samvel Petrossian as its new Chief Executive Officer
and Chief Financial Officer and Director of the Company effective July 24, 2006.
Samvel Petrossian has extensive experience business development and
reorganization, with the proven ability to coordinate projects on a National and
an International scale. Mr. Petrossian has for the past 30 years developed and
built businesses in both the United States and in Europe. Within the last five
years, Mr. Petrossian leveraged previous successes in the restaurant business to
become President of Simon & Peter Enterprises, a food service company in Sherman
Oaks, CA. Mr. Petrossian attained a Communications degree from the Institute of
Culture in Moscow, Russia in 1983. He is fluent in the Russian, Armenian, and
English languages.
Under an agreement with the Company, Mr. Petrossian shall be paid a monthly
salary of $5,000.00 for serving as an officer and director of the Company. At
this time, he has not been granted options to acquire any of the Company's stock
nor is he participating in any other equity-based compensation plan.
In his role as Chief Executive Officer and Chief Financial Officer, Mr.
Petrossian will be responsible for managing all aspects of the Company,
including the acquisition of oil and gas properties and the exploration, drill
programs and budgets for the Company's acquired oil and gas projects.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
National Healthcare Technology, Inc.
By: /s/ Samvel Petrossian
--------------------------------
Samvel Petrossian,
Chief Executive Officer
Date: July 28, 2006
-3-